by MM360 Staff | May 5, 2025 | Uncategorized
Source: CureToday articles Panelists discuss how to communicate genomic testing results to patients and make shared treatment decisions, particularly when multiple targeted therapy options are available for patients with ESR1 and PIK3CA mutations. Read...
by MM360 Staff | May 5, 2025 | Uncategorized
Source: CureToday articles Panelists discuss how to approach second-line therapy decisions for patients with metastatic breast cancer, emphasizing the importance of biomarker testing, including ESR1 mutations, and considering patient-specific factors. Read...
by MM360 Staff | May 5, 2025 | Uncategorized
Source: CureToday articles In this Q&A, Carly Stafford Dixon discusses her lymphoma journey, recovery with CAR T therapy, and mission to raise support for young adults with cancer. Read More
by MM360 Staff | May 4, 2025 | Uncategorized
Source: CureToday articles Dr. Neha Mehta-Shah shares how patients can better understand their subtype of rare lymphoma, as well as expands on the challenges these patients face. Read More
by MM360 Staff | May 4, 2025 | Uncategorized
Source: CureToday articles It is with great pride and admiration that I nominate Diane Hudson, RN, OCN, for the Extraordinary Healer Award for Oncology Nursing. Read More
by MM360 Staff | May 3, 2025 | Uncategorized
Source: CureToday articles Dr. Cathy Eng discusses the importance of the Braftovi plus Erbitux FDA approval for treatment-naive BRAF V600E+ metastatic colorectal cancer. Read More
